Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "N06DA" (75)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Donepezil (N06DA02) 28 products
WHO-DDD
DrugBank.ca
L
IP
CI
Aricept Evess 5 mg
28 Tablet(s)
49.52
70.05
10 %
Melting tablets: Donepezili Hydrochloridum 5 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Aricept Evess 5 mg
98 Tablet(s)
173.36
204.05
10 %
Melting tablets: Donepezili Hydrochloridum 5 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Aricept Evess 10 mg
28 Tablet(s)
49.52
70.05
10 %
Melting tablets: Donepezili Hydrochloridum 10 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Aricept Evess 10 mg
98 Tablet(s)
173.36
204.05
10 %
Melting tablets: Donepezili Hydrochloridum 10 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Aricept 5 mg
28 Tablet(s)
49.52
70.05
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Aricept 5 mg
98 Tablet(s)
173.36
204.05
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Aricept 10 mg
28 Tablet(s)
49.52
70.05
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Aricept 10 mg
98 Tablet(s)
173.36
204.05
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Donepezil NOBEL lingual 5 mg
28
45.30
65.70
10 %
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
Donepezil NOBEL lingual 5 mg
98
157.61
187.85
10 %
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Donepezil NOBEL lingual 10 mg
28
45.30
65.70
10 %
Melting tablets: Donepezili Hydrochloridum 10 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Donepezil NOBEL lingual 10 mg
98
157.61
187.85
10 %
Melting tablets: Donepezili Hydrochloridum 10 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
Donepezil Sandoz 5 mg
28 Tablet(s)
45.03
65.45
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Donepezil Sandoz 5 mg
98 Tablet(s)
157.61
187.85
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Donepezil Sandoz 10 mg
28 Tablet(s)
45.03
65.45
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Donepezil Sandoz 10 mg
98 Tablet(s)
157.61
187.85
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Donepezil Spirig HC
28 Tablet(s)
45.55
66.00
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
L
IP
CI
Donepezil Spirig HC
98 Tablet(s)
157.61
187.85
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
L
IP
CI
Donepezil Spirig HC
28 Tablet(s)
45.55
66.00
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Donepezil Spirig HC
98 Tablet(s)
157.61
187.85
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Donepezil-Mepha 5 mg
30 Tablet(s)
48.86
69.40
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Donepezil-Mepha 5 mg
50 Tablet(s)
81.28
104.80
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Donepezil-Mepha 5 mg
100 Tablet(s)
160.82
191.15
10 %
Coated tablets: Donepezili Hydrochloridum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Donepezil-Mepha 10 mg
30 Tablet(s)
48.86
69.40
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Donepezil-Mepha 10 mg
50 Tablet(s)
81.28
104.80
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Donepezil-Mepha 10 mg
100 Tablet(s)
160.82
191.15
10 %
Coated tablets: Donepezili Hydrochloridum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Donepezil Sandoz 5 mg
50 Tablet(s)
PR
PR
k.A.
Coated tablets: Donepezili Hydrochloridum 5 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Donepezil Sandoz 10 mg
50 Tablet(s)
PR
PR
k.A.
Coated tablets: Donepezili Hydrochloridum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Rivastigmine (N06DA03) 35 products
WHO-DDD
DrugBank.ca
L
IP
CI
CM
Rivastigmin Patch Sandoz 5
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 9 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
CM
Rivastigmin Patch Sandoz 10
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 18 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
CM
Rivastigmin Patch Sandoz 10
60
79.02
102.35
10 %
Transdermal patch: Rivastigminum 18 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Rivastigmin Patch Sandoz 15
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 27 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Rivastigmin Patch Sandoz 15
60
79.02
102.35
10 %
Transdermal patch: Rivastigminum 27 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
Rivasur zweimal
wöchentlich 4,6 mg/24
Stunden
8
PR
PR
k.A.
Transdermal patch: (Transdermales Pflaster): Rivastigminum 25.92 mg
Luye Pharma
Switzerland AG
B
FB
G
Rivasur zweimal
wöchentlich 4,6 mg/24
Stunden
16
PR
PR
k.A.
Transdermal patch: (Transdermales Pflaster): Rivastigminum 25.92 mg
Luye Pharma
Switzerland AG
B
FB
G
Rivasur zweimal
wöchentlich 9,5 mg/24
Stunden
8
PR
PR
k.A.
Transdermal patch: (Transdermales Pflaster): Rivastigminum 51.84 mg
Luye Pharma
Switzerland AG
B
FB
G
Rivasur zweimal
wöchentlich 9,5 mg/24
Stunden
16
PR
PR
k.A.
Transdermal patch: (Transdermales Pflaster): Rivastigminum 51.84 mg
Luye Pharma
Switzerland AG
B
FB
G
L
IP
CI
Exelon Patch 5
30 plaster(s)
53.24
73.45
20 %
Transdermal patch: Rivastigminum 9 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exelon Patch 10
30 plaster(s)
53.24
73.45
20 %
Transdermal patch: Rivastigminum 18 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exelon Patch 10
60 plaster(s)
106.48
130.55
20 %
Transdermal patch: Rivastigminum 18 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exelon Patch 15
30 plaster(s)
53.24
73.45
20 %
Transdermal patch: Rivastigminum 27 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Exelon Patch 15
60 plaster(s)
106.48
130.55
20 %
Transdermal patch: Rivastigminum 27 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Rivastigmin Zentiva Patch 4.6
mg/24 h
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 6.9 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Rivastigmin Zentiva Patch 9.5
mg/24 h
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 13.8 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Rivastigmin Zentiva Patch 9.5
mg/24 h
2 x 30
79.02
102.35
10 %
Transdermal patch: Rivastigminum 13.8 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Rivastigmin Zentiva Patch
13.3 mg/24 h
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 19.2 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Rivastigmin Zentiva Patch
13.3 mg/24 h
2 x 30
79.02
102.35
10 %
Transdermal patch: Rivastigminum 19.2 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Rivastigmin-Mepha Patch 4.6
mg/24 h
30
39.51
59.40
10 %
Transdermale Pflaster: Rivastigminum 6.4 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivastigmin-Mepha Patch 9.5
mg/24 h
30
39.51
59.40
10 %
Transdermale Pflaster: Rivastigminum 12.8 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivastigmin-Mepha Patch 9.5
mg/24 h
2 x 30
79.02
102.35
10 %
Transdermale Pflaster: Rivastigminum 12.8 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivastigmin-Mepha Patch
13.3 mg/24 h
30
39.51
59.40
10 %
Transdermale Pflaster: Rivastigminum 19.2 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Rivastigmin-Mepha Patch
13.3 mg/24 h
2 x 30
79.02
102.35
10 %
Transdermale Pflaster: Rivastigminum 19.2 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Exelon 1,5 mg
-
T
28 Capsule(s)
23.73
42.20
10 %
Capsules: Rivastigminum 1.5 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 1,5 mg
-
T
56 Capsule(s)
42.53
62.65
10 %
Capsules: Rivastigminum 1.5 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 1,5 mg
-
T
112 Capsule(s)
93.27
117.85
10 %
Capsules: Rivastigminum 1.5 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 3 mg
-
T
28 Capsule(s)
23.73
42.20
10 %
Capsules: Rivastigminum 3 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 3 mg
-
T
56 Capsule(s)
42.53
62.65
10 %
Capsules: Rivastigminum 3 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 3 mg
-
T
112 Capsule(s)
93.27
117.85
10 %
Capsules: Rivastigminum 3 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 4,5 mg
-
T
28 Capsule(s)
23.73
42.20
10 %
Capsules: Rivastigminum 4.5 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 4,5 mg
-
T
112 Capsule(s)
93.27
117.85
10 %
Capsules: Rivastigminum 4.5 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 6 mg
-
T
28 Capsule(s)
23.73
42.20
10 %
Capsules: Rivastigminum 6 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 6 mg
-
T
112 Capsule(s)
93.27
117.85
10 %
Capsules: Rivastigminum 6 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Exelon 2 mg/ml
120 ml
68.98
91.45
10 %
Solution (oral): Rivastigminum 2 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
Galantamine (N06DA04) 12 products
WHO-DDD
DrugBank.ca
L
IP
CI
Reminyl PR 8 mg
28 Capsule(s)
43.17
63.10
10 %
Capsules: Galantaminum 8 mg
Essential Pharma
Switzerland GmbH
B / SL / SO
FB
G
L
IP
CI
Reminyl PR 16 mg
28 Capsule(s)
43.17
63.10
10 %
Capsules: Galantaminum 16 mg
Essential Pharma
Switzerland GmbH
B / SL / SO
FB
G
L
IP
CI
Reminyl PR 24 mg
28 Capsule(s)
43.17
63.10
10 %
Capsules: Galantaminum 24 mg
Essential Pharma
Switzerland GmbH
● 
B / SL / SO
FB
G
L
IP
CI
Galantamin SR Zentiva 8 mg
28
39.25
59.10
10 %
Delayed release capsules: Galantaminum 8 mg
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
CI
Galantamin SR Zentiva 16 mg
28
39.25
59.10
10 %
Delayed release capsules: Galantaminum 16 mg
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
CI
Galantamin SR Zentiva 24 mg
28
39.25
59.10
10 %
Delayed release capsules: Galantaminum 24 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Galantamin-Mepha retard 8 mg
7 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 8 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 8 mg
28 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 8 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 16 mg
28 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 16 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 16 mg
84 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 16 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 24 mg
28 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 24 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 24 mg
84 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 24 mg
Mepha Pharma AG
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home